Langhi Mariana M, Abdo Andre N R, Putz Juliana F B, Carvalho Lizandra M, Loss Silvia R, Zampieri Filho Jose P, Bordin Jose O, Bachour Phillip, Baiocchi Otavio C C G
Oncology Center at Hospital Alemao Oswaldo Cruz, Sao Paulo, Brazil.
J Med Cases. 2020 Jul;11(7):204-206. doi: 10.14740/jmc3518. Epub 2020 Jun 29.
Since December 2019, a newly identified coronavirus disease 2019 (COVID-19) has spread in China and the rest of world. There are many doubts regarding pathogenesis as well complications due to COVID-19. We report a case with association between thrombocytopenia and the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection after exclusion of other possible etiology in a patient with previous controlled idiopathic thrombocytopenic purpura.
自2019年12月以来，一种新发现的冠状病毒病2019（COVID-19）在中国及世界其他地区传播。关于COVID-19的发病机制以及并发症存在许多疑问。我们报告了一例既往特发性血小板减少性紫癜病情得到控制的患者，在排除其他可能病因后，发现血小板减少与新型严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染有关。
